CN104622914A - Vaginal probiotic suppository - Google Patents
Vaginal probiotic suppository Download PDFInfo
- Publication number
- CN104622914A CN104622914A CN201510010621.2A CN201510010621A CN104622914A CN 104622914 A CN104622914 A CN 104622914A CN 201510010621 A CN201510010621 A CN 201510010621A CN 104622914 A CN104622914 A CN 104622914A
- Authority
- CN
- China
- Prior art keywords
- suppository
- vaginal
- probiotics
- gram
- vagina
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention provides a vaginal probiotic suppository, and relates to a method for putting vaginal probiotic suppository to treat patients requiring treatment, particularly patients with vaginal and progenital inflammation when the effect for treating the patients by using antibacterial medicines, antifungal medicines and vaginal probiotics on current market is not good. The vaginal probiotic suppository is prepared by using probiotics as a main material, and the probiotics can be clostridium butyricum, bifidobacterium and bacillus licheniformis. The probiotic suppository can be used for treating wide vaginal inflammations, including colpitis mycotica, bifidobacterium, senile vaginitis and other gynecologic inflammations, and is used for combined treatment including antibacterial medicines, antifungal medicines or probiotic suppository.
Description
The present invention relates to a kind of medicine, be mainly used in treatment woman vagina and episioitis.
At present, treat vaginitis in hospital and use antimicrobial drug, antifungal agent, kill or suppress pathogen, if once it thoroughly can not be killed, will soon stage a comeback.Antibacterial, fungus can produce drug resistance on the one hand; Antibiotic can cause disturbed vaginal flora, scratchiness recurrent exerbation on the other hand.Chinese medicine is better to gynecological inflammation effect, but treatment time is long.The probiotic bacteria----lactobacillus that supplementary woman vagina popular on market is main, treats the prolonged vaginitis of not healing, easily recurring, and has splendid rehabilitation rate 87%-100%, and extremely low relapse rate.Generally, the same day pruritus, pain just alleviates, with a week, pruritus, pain are all eliminated, but need adhere to two months.And lactic acid bacteria powder needs demibain, the vaginal wall adhesion that lactic acid bacteria capsule is easy and impaired, causes pain, all not ideal enough in a word.
The object of this invention is to provide one treat vaginitis rapidly, vaginal suppository easily.
In order to achieve the above object, the present invention adopts clostridium butyricum, bacillus bifidus or Bacillus licheniformis to promote vagina probiotics growth, instead of supplement the main probiotic bacteria of woman vagina, because flora in vagina the field planting easier than the extraneous flora supplemented that vagina self produces.Utilize clostridium butyricum, bacillus bifidus or Bacillus licheniformis promote vagina probiotics growth, suppress vagina and the field planting of pudendum fastbacteria, pathogenic theory, clostridium butyricum or bacillus bifidus are made vaginal suppository, such as miconazole, be placed into vagina.Thus play rapid, the colpitic effect of convenient treatment, make vaginitis patient remove pruritus, pain.According to the above, vagina probiotics suppository probiotic bacteria of the present invention makes major ingredient, and add appropriate microcrystalline Cellulose, magnesium stearate, starch, glucose make vaginal suppository as substrate, vagina clostridium butyricum bolt is not less than 1.5 × 10 containing viable count
8cFU/ gram, bacillus bifidus bolt is not less than 2.38 × 10 containing viable count
8cFU/ gram, the ratio of the parts by weight of raw materials of adding in its formula is: microcrystalline Cellulose: magnesium stearate: starch: glucose=1 gram: 1 gram: 1 gram: 1 gram.Get clostridium butyricum and (be not less than 31.5 × 10 containing clostridium butyricum viable count
7cFU) or bacillus bifidus (be not less than 5.0 × 10 containing the number of active bifid bacteria
8cFU) make 1 vaginal suppository, insert pruritus on the same day, pain is just eliminated.Add with 1 again, just can reach extremely low relapse rate.
In sum, the present invention can treat vaginitis more rapidly, easily than current Lactobacillus powder or capsule, antimicrobial drug, antifungal agent.
Claims (5)
1. vagina probiotics suppository, is characterized in that: be that vaginal suppository made by major ingredient with probiotic bacteria.
2. vagina probiotics suppository according to claim 1, is characterized in that: described probiotic bacteria is the combination in any of one or more of clostridium butyricum, bacillus bifidus, Bacillus licheniformis.
3. vagina probiotics suppository according to claim 1, is characterized in that: vagina probiotics suppository makes major ingredient with probiotic bacteria, adds microcrystalline Cellulose, magnesium stearate, starch, glucose make vaginal suppository as substrate.Vagina clostridium butyricum bolt is not less than 1.5 × 10 containing viable count
8cFU/ gram, bacillus bifidus bolt is not less than 2.38 × 10 containing viable count
8cFU/ gram, the ratio of the parts by weight of raw materials of adding in its formula is: microcrystalline Cellulose: magnesium stearate: starch: glucose=1 gram: 1 gram: 1 gram: 1 gram.
4. vagina probiotics suppository according to claim 1, is characterized in that: every described, clostridium butyricum bolt is not less than 31.5 × 10 containing clostridium butyricum viable count
7cFU.
5. vagina probiotics suppository according to claim 1, is characterized in that: every described, bacillus bifidus bolt is not less than 5.0 × 10 containing the number of active bifid bacteria
8cFU.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510010621.2A CN104622914A (en) | 2015-01-06 | 2015-01-06 | Vaginal probiotic suppository |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510010621.2A CN104622914A (en) | 2015-01-06 | 2015-01-06 | Vaginal probiotic suppository |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104622914A true CN104622914A (en) | 2015-05-20 |
Family
ID=53202476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510010621.2A Pending CN104622914A (en) | 2015-01-06 | 2015-01-06 | Vaginal probiotic suppository |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104622914A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112057480A (en) * | 2020-09-29 | 2020-12-11 | 深圳市东荣生物科技有限责任公司 | Microbial preparation for treating vaginitis |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1357038A (en) * | 1999-06-21 | 2002-07-03 | Vsl制药有限公司 | Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| CN1663573A (en) * | 2004-03-04 | 2005-09-07 | 青岛东海药业有限公司 | A stable and safe microecological formulation, its preparation and usage |
| CN101982180A (en) * | 2010-11-01 | 2011-03-02 | 西藏贝珠雅药业有限公司 | Novel probiotic viable bacteria vaginal suppository body |
| CN102256610A (en) * | 2008-12-18 | 2011-11-23 | 伯拉考成像股份公司 | Probiotic formulations |
-
2015
- 2015-01-06 CN CN201510010621.2A patent/CN104622914A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1357038A (en) * | 1999-06-21 | 2002-07-03 | Vsl制药有限公司 | Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| CN1663573A (en) * | 2004-03-04 | 2005-09-07 | 青岛东海药业有限公司 | A stable and safe microecological formulation, its preparation and usage |
| CN102256610A (en) * | 2008-12-18 | 2011-11-23 | 伯拉考成像股份公司 | Probiotic formulations |
| CN101982180A (en) * | 2010-11-01 | 2011-03-02 | 西藏贝珠雅药业有限公司 | Novel probiotic viable bacteria vaginal suppository body |
Non-Patent Citations (3)
| Title |
|---|
| 刘东红: "微生态制剂的进展与临床应用评价", 《中国医院用药评价与分析》 * |
| 陈万祥等: "地衣芽孢杆菌阴道栓的试制与临床应用", 《中国微生态学杂志》 * |
| 陈万祥等: "地衣芽孢杆菌阴道栓的试制与临床应用", 《中国微生态学杂质》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112057480A (en) * | 2020-09-29 | 2020-12-11 | 深圳市东荣生物科技有限责任公司 | Microbial preparation for treating vaginitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102028705B (en) | Gynecologic article containing biological antifungal components | |
| RU2004130876A (en) | STRAINS LACTOBACILLUS | |
| CN111991429B (en) | Application of lactobacillus reuteri in preparation of products for resisting oral bacterial infection | |
| JP2013522315A5 (en) | ||
| CN103409334B (en) | Inhibit the Bacillus acidi lactici and application thereof of vaginitis pathogen | |
| CN109820044A (en) | A kind of strengthen immunity and assist antianaphylactic probiotics solid beverage formula | |
| CN105288218A (en) | Probiotics composite | |
| CN104382685A (en) | Method for preparing human vaginal microecological preparation-probiotics condom | |
| CN103263444B (en) | Micro-ecological compound preparation for preventing and treating stress diarrhoea of goat and preparation method thereof | |
| CN109985069B (en) | Probiotic compositions and uses thereof | |
| TWI729384B (en) | Probiotic bacteria for urogenital healthcare and uses thereof | |
| CN106138111A (en) | A kind of compositions for improving vaginal health | |
| CN104622914A (en) | Vaginal probiotic suppository | |
| CN102000197B (en) | Gargle for treating periapicalitis | |
| CN101690734A (en) | Lactobacillus vaginal capsule and preparation method thereof | |
| CN104069124A (en) | Composition and preparation for gynecologic infections | |
| CN101982180A (en) | Novel probiotic viable bacteria vaginal suppository body | |
| CN105853449B (en) | A kind of antibacterial compound drug of amikacin sulfate for injection | |
| TWI412371B (en) | A novel strain of lactobacillus and its use in inhibition of vaginitis | |
| CN108354952A (en) | Vagina infusion and its mixing arrangement set group and application method | |
| CN104435291A (en) | Medicine composition for preventing and treating pig intestinal inflammation | |
| EP1911455B1 (en) | Topical vaginal pharmaceutical compositions | |
| CN111281896B (en) | Composite microbial inoculum for adjusting micro-ecological balance of gynecology | |
| CN201840678U (en) | Microecological vagina stype | |
| CN112007067A (en) | Privacy protecting probiotic compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150520 |
|
| WD01 | Invention patent application deemed withdrawn after publication |